• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植前CRP及白细胞介素-6家族细胞因子水平;对异基因干细胞移植后结局的影响

Pretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation.

作者信息

Tvedt Tor Henrik, Lie Stein Atle, Reikvam Håkon, Rye Kristin Paulsen, Lindås Roald, Gedde-Dahl Tobias, Ahmed Aymen Bushra, Bruserud Øystein

机构信息

Section for Hematology, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.

Department of Clinical Dentistry, University of Bergen, 5020 Bergen, Norway.

出版信息

Int J Mol Sci. 2016 Nov 1;17(11):1823. doi: 10.3390/ijms17111823.

DOI:10.3390/ijms17111823
PMID:27809289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5133824/
Abstract

Several pretransplant factors, including CRP (C-reactive protein) levels, reflect the risk of complications after allogeneic stem cell transplantation. IL-6 induces CRP increase, and we therefore investigated the effects of pretransplant IL-6, soluble IL-6 receptors, IL-6 family cytokines and CRP serum levels on outcome for 100 consecutive allotransplant recipients. All patients had related donors, none had active infections and 99 patients were in complete remission before conditioning. The incidence of acute graft versus host disease (aGVHD) requiring treatment was 40%, survival at Day +100 82%, and overall survival 48%. Despite a significant correlation between pretransplant CRP and IL-6 levels, only CRP levels significantly influenced transplant-related mortality (TRM). However, CRP did not influence overall survival (OS). Pretransplant IL-31 influenced late TRM. Finally, there was a significant association between pretransplant IL-6 and early postconditioning weight gain (i.e., fluid retention), and this fluid retention was a risk factor for aGVHD, TRM and OS. To conclude, pretransplant CRP, IL-31 and early posttransplant fluid retention were independent risk factors for TRM and survival after allotransplantation.

摘要

包括C反应蛋白(CRP)水平在内的几种移植前因素反映了异基因干细胞移植后并发症的风险。白细胞介素-6(IL-6)可诱导CRP升高,因此我们研究了移植前IL-6、可溶性IL-6受体、IL-6家族细胞因子和CRP血清水平对100例连续同种异体移植受者预后的影响。所有患者均有相关供者,均无活动性感染,99例患者在预处理前处于完全缓解状态。需要治疗的急性移植物抗宿主病(aGVHD)发生率为40%,+100天时生存率为82%,总生存率为48%。尽管移植前CRP与IL-6水平之间存在显著相关性,但只有CRP水平显著影响移植相关死亡率(TRM)。然而,CRP并不影响总生存率(OS)。移植前IL-31影响晚期TRM。最后,移植前IL-6与预处理后早期体重增加(即液体潴留)之间存在显著关联,这种液体潴留是aGVHD、TRM和OS的危险因素。总之,移植前CRP、IL-31和移植后早期液体潴留是同种异体移植后TRM和生存的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23c/5133824/8d9c348361c2/ijms-17-01823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23c/5133824/3f87ee0a8417/ijms-17-01823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23c/5133824/8d9c348361c2/ijms-17-01823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23c/5133824/3f87ee0a8417/ijms-17-01823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23c/5133824/8d9c348361c2/ijms-17-01823-g002.jpg

相似文献

1
Pretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation.移植前CRP及白细胞介素-6家族细胞因子水平;对异基因干细胞移植后结局的影响
Int J Mol Sci. 2016 Nov 1;17(11):1823. doi: 10.3390/ijms17111823.
2
A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation.白细胞介素-6 受体中单核苷酸多态性及其对同种异体造血干细胞移植前后血清介质水平和移植后结局影响的初步研究。
Clin Exp Immunol. 2018 Jul;193(1):130-141. doi: 10.1111/cei.13124. Epub 2018 Apr 1.
3
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.预处理时的C反应蛋白是降低强度异基因造血细胞移植后预后的一个预测指标。
Biol Blood Marrow Transplant. 2008 Nov;14(11):1209-16. doi: 10.1016/j.bbmt.2008.08.004.
4
Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.移植前血清C反应蛋白(CRP)值可能预测异基因造血干细胞移植后的急性移植物抗宿主病和非复发死亡率。
Biol Blood Marrow Transplant. 2008 May;14(5):510-7. doi: 10.1016/j.bbmt.2008.02.008.
5
Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients.异基因造血干细胞受体中C反应蛋白、白细胞介素-6和降钙素原水平的评估。
Eur J Haematol. 2006 Feb;76(2):93-101. doi: 10.1111/j.0902-4441.2005.00568.x.
6
Prognostic role of pre-transplantation serum C-reactive protein levels in patients with acute leukemia undergoing myeloablative allogeneic stem cell transplantation.移植前血清 C 反应蛋白水平对接受清髓性异基因造血干细胞移植的急性白血病患者的预后作用。
Clin Transplant. 2012 Sep-Oct;26(5):E513-21. doi: 10.1111/ctr.12028.
7
Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.移植前血清铁蛋白和 C 反应蛋白水平对异基因造血干细胞移植后慢性移植物抗宿主病发生率的不同影响。
Int J Hematol. 2013 Jan;97(1):109-16. doi: 10.1007/s12185-012-1229-0. Epub 2012 Dec 7.
8
Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants.白细胞介素-18结合蛋白在异基因外周血干细胞移植后的急性移植物抗宿主病及植入中的作用
J Hematother Stem Cell Res. 2001 Dec;10(6):769-76. doi: 10.1089/152581601317210863.
9
C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation.急性移植物抗宿主病诊断时 C 反应蛋白水平可预测激素耐药疾病、治疗相关死亡率和异基因造血干细胞移植后的总生存率。
Biol Blood Marrow Transplant. 2018 Mar;24(3):600-607. doi: 10.1016/j.bbmt.2017.10.025. Epub 2017 Oct 23.
10
Serum cytokine concentrations and acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: concurrent measurement of ten cytokines and their respective ratios using cytometric bead array.异基因外周血干细胞移植后的血清细胞因子浓度与急性移植物抗宿主病:使用细胞计数珠阵列同时检测十种细胞因子及其各自的比率
Int J Mol Med. 2006 May;17(5):881-5.

引用本文的文献

1
Ferritin in Acute Myeloid Leukemia: Not Only a Marker of Inflammation and Iron Overload, but Also a Regulator of Cellular Iron Metabolism, Signaling and Communication.急性髓系白血病中的铁蛋白:不仅是炎症和铁过载的标志物,也是细胞铁代谢、信号传导和通讯的调节因子。
Int J Mol Sci. 2025 Jun 15;26(12):5744. doi: 10.3390/ijms26125744.
2
The function of the complement system remains fully intact throughout the course of allogeneic stem cell transplantation.补体系统的功能在整个异基因干细胞移植过程中保持完全完整。
Front Immunol. 2024 Jun 13;15:1422370. doi: 10.3389/fimmu.2024.1422370. eCollection 2024.
3
Musculoskeletal Chronic Graft versus Host Disease-A Rare Complication to Allogeneic Hematopoietic Stem Cell Transplant: A Case-Based Report and Review of the Literature.

本文引用的文献

1
Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single-center cohort study.儿童干细胞移植受者毛细血管渗漏综合征的流行病学、危险因素及预后:一项回顾性单中心队列研究
Pediatr Transplant. 2016 Dec;20(8):1132-1136. doi: 10.1111/petr.12831. Epub 2016 Oct 13.
2
Pretransplant β2-Microglobulin Is Associated with the Risk of Acute Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplant.移植前β2微球蛋白与异基因造血细胞移植后急性移植物抗宿主病的风险相关。
Biol Blood Marrow Transplant. 2016 Jul;22(7):1329-1332. doi: 10.1016/j.bbmt.2016.03.024. Epub 2016 Apr 1.
3
肌肉骨骼慢性移植物抗宿主病-异基因造血干细胞移植的罕见并发症:基于病例的报告和文献复习。
Curr Oncol. 2022 Nov 3;29(11):8415-8430. doi: 10.3390/curroncol29110663.
4
Pretransplant Systemic Lipidomic Profiles in Allogeneic Stem Cell Transplant Recipients.异基因干细胞移植受者移植前的系统脂质组学概况
Cancers (Basel). 2022 Jun 13;14(12):2910. doi: 10.3390/cancers14122910.
5
A systematic review on disease-drug-drug interactions with immunomodulating drugs: A critical appraisal of risk assessment and drug labelling.免疫调节药物相关药物-疾病-药物相互作用的系统评价:风险评估和药物标签的批判性评估。
Br J Clin Pharmacol. 2022 Oct;88(10):4387-4402. doi: 10.1111/bcp.15372. Epub 2022 Jun 16.
6
Endocan in Acute Leukemia: Current Knowledge and Future Perspectives.内消蛋白在急性白血病中的作用:现状与展望。
Biomolecules. 2022 Mar 24;12(4):492. doi: 10.3390/biom12040492.
7
Chondroitin Sulfate and Fucosylated Chondroitin Sulfate as Stimulators of Hematopoiesis in Cyclophosphamide-Induced Mice.硫酸软骨素和岩藻糖基化硫酸软骨素对环磷酰胺诱导的小鼠造血的刺激作用
Pharmaceuticals (Basel). 2021 Oct 24;14(11):1074. doi: 10.3390/ph14111074.
8
Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences.血液系统恶性肿瘤免疫治疗中的细胞因子释放综合征:背后的生物学机制及可能的临床后果
J Clin Med. 2021 Nov 6;10(21):5190. doi: 10.3390/jcm10215190.
9
Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer-What Can We Learn from the Hematological Experience?联合C反应蛋白与新型炎症参数作为癌症的预测指标——我们能从血液学经验中学到什么?
Cancers (Basel). 2020 Jul 19;12(7):1966. doi: 10.3390/cancers12071966.
10
The Biological Context of C-Reactive Protein as a Prognostic Marker in Renal Cell Carcinoma: Studies on the Acute Phase Cytokine Profile.C反应蛋白作为肾细胞癌预后标志物的生物学背景:急性期细胞因子谱研究
Cancers (Basel). 2020 Jul 19;12(7):1961. doi: 10.3390/cancers12071961.
Metabolic Serum Profiles for Patients Receiving Allogeneic Stem Cell Transplantation: The Pretransplant Profile Differs for Patients with and without Posttransplant Capillary Leak Syndrome.
接受异基因干细胞移植患者的代谢血清谱:移植前有和没有移植后毛细血管渗漏综合征患者的谱不同。
Dis Markers. 2015;2015:943430. doi: 10.1155/2015/943430. Epub 2015 Nov 2.
4
Possible mechanisms of C-reactive protein mediated acute myocardial infarction.C反应蛋白介导急性心肌梗死的可能机制。
Eur J Pharmacol. 2015 Aug 5;760:72-80. doi: 10.1016/j.ejphar.2015.04.010. Epub 2015 Apr 18.
5
Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation.肺实质来源的白细胞介素-6在异基因干细胞移植后促进白细胞介素-17A依赖性急性肺损伤。
Blood. 2015 Apr 9;125(15):2435-44. doi: 10.1182/blood-2014-07-590232. Epub 2015 Feb 11.
6
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.异体造血干细胞移植后加用托珠单抗抑制白细胞介素-6 预防移植物抗宿主病:一项 1/2 期试验。
Lancet Oncol. 2014 Dec;15(13):1451-1459. doi: 10.1016/S1470-2045(14)71017-4. Epub 2014 Nov 14.
7
Preconditioning serum levels of endothelial cell-derived molecules and the risk of posttransplant complications in patients treated with allogeneic stem cell transplantation.异基因干细胞移植患者内皮细胞衍生分子的预处理血清水平与移植后并发症风险
J Transplant. 2014;2014:404096. doi: 10.1155/2014/404096. Epub 2014 Oct 8.
8
Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities.白细胞介素-6:从基础生物学到促炎活性的选择性阻断
Semin Immunol. 2014 Feb;26(1):2-12. doi: 10.1016/j.smim.2013.11.002. Epub 2013 Dec 8.
9
Pretransplant C-reactive protein as A prognostic marker in allogeneic stem cell transplantation.移植前 C 反应蛋白作为异基因干细胞移植的预后标志物。
Scand J Immunol. 2014 Mar;79(3):206-13. doi: 10.1111/sji.12137.
10
Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study.熊去氧胆酸预防异基因干细胞移植:一项随机研究的长期随访结果显示生存改善。
Biol Blood Marrow Transplant. 2014 Jan;20(1):135-8. doi: 10.1016/j.bbmt.2013.10.014. Epub 2013 Oct 17.